Research has found that carmofur prevents cell cycle progression by reducing E2F8 transcription in temozolomide-resistant glioblastoma cells. Other studies have explored the role of various enzymes and lipids, including ceramides and sphingolipids, in cancer cell progression and immune microenvironments. The relationship between these findings and the effect of carmofur on glioblastoma cells is not clear from the available information.